You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
While working on #634, I noticed MAR01227 and MAR01185: these appear in between a bunch of reactions that clearly represent β-oxidation of fatty acids, but this chemistry does not correspond to any steps or combination of steps of β-oxidation (or α-, or ω-oxidation):
Also those oxygen molecules seem to be coming from the ketone groups on the hydroxydodecenoates, which seems dubiously real. If instead 4(R/S)-hydroxy-docec-(6Z)-enoate went through one round of normal β-oxidation (see thesepapers), that would look like:
4(R/S)-hydroxy-dodec-(6Z)-enoyl-CoA + FAD -> 4(R/S)-hydroxy-dodec-(2Z,6Z)-dienoyl-CoA + FADH2 catalyzed by ACAD9, ACADL, or ACADM (sources: 1, 2, 3)
4(R/S)-hydroxy-dodec-(2Z,6Z)-dienoyl-CoA + H2O -> 3(S),4(R)-dihydroxy-dodec-(6Z)-dienoyl-CoA catalyzed by HADHA
3(S),4(R/S)-dihydroxy-dodec-(6Z)-dienoyl-CoA + NAD+ -> 3-oxo-4(R/S)-hydroxy-dodec-(6Z)-dienoyl-CoA + H+ catalyzed by HADHA
3-oxo-4(R/S)-hydroxy-dodec-(6Z)-dienoyl-CoA + CoA -> 2(R/S)-hydroxy-dec-(4Z)-enoyl-CoA + acetyl-CoA catalyzed by HADHB or SCP2
But then there's a problem: 2-hydroxy-acyl-CoAs cannot undergo β-oxidation, so if one is formed as an intermediate during β-oxidation, HACL1 or ILVBL converts the 2-hydroxy-acyl-CoA into an aldehyde with one fewer carbon than the 2-hydroxyacyl-CoA while releasing a formyl-CoA, then ALDH3A2 converts that aldehyde into a carboxylic acid (source), which can then be turned into an acyl-CoA by an acyl-CoA syntheases and resume “normal” β-oxidation. None of these enzymes are localized to mitochondria: HACL1 is in peroxisomes, ILVBL is in the E.R., and ALDH3A2 can be in either peroxisomes or the E.R. I'm proposing a series of reactions that takes the E.R. route and rejoins the ordinary β-oxidation pathway at (2E)-nonenoyl-CoA (MAM00056m):
2(R/S)-hydroxy-dec-(4Z)-enoyl-CoA + H2O -> 2(R/S)-hydroxy-dec-(4Z)-enoate [m] + CoA + H+ catalyzed by ACOT2, ACOT8, ACOT9, ACOT11, or ACAA2 (sources: 1, 2, 3, 4)
2(R/S)-hydroxy-dec-(4Z)-enoate + ATP + CoA -> 2(R/S)-hydroxy-dec-(4Z)-enoyl-CoA + AMP + PPi catalyzed by SLC27A4 (sources: figure 3 of this paper and table 2 of this paper)
2(R/S)-hydroxy-dec-(4Z)-enoyl-CoA -> 3Z-nonenal + formyl-CoA by ILVBL
3Z-noneoate [m] + ATP + CoA -> 3Z-nonenoyl-CoA + AMP + PPi catalyzed by ACSM1 (source)
3Z-nonenoyl-CoA -> 2E-nonenoyl-CoA catalyzed by ECI1
Proposed Changes:
Create a new gene entry for ILVBL (ENSG00000105135)
Create new metabolites for mitochondrial 4-hydroxy-dodec-(2Z,6Z)-dienoyl-CoA, formula: C33H50N7O18P3S4-, charge: -4
Create new metabolites for mitochondrial 3(S),4-dihydroxy-dodec-(6Z)-dienoyl-CoA, formula: C33H52N7O19P3S4-, charge: -4
Create new metabolites for mitochondrial 3-oxo-4-hydroxy-dodec-(6Z)-dienoyl-CoA, formula: C33H50N7O19P3S4-, charge: -4
Create new metabolites for mitochondrial 2-hydroxy-dec-(4Z)-enoyl-CoA, formula: C31H48N7O18P3S4-, charge: -4
Create new metabolites for mitochondrial 2-hydroxy-dec-(4Z)-enoate, formula: C10H17O3, charge: -1
Create new metabolites for cytosolic 2-hydroxy-dec-(4Z)-enoate, formula: C10H17O3, charge: -1
Create new metabolites for E.R. 2-hydroxy-dec-(4Z)-enoate, formula: C10H17O3, charge: -1
Create new metabolites for E.R. 2-hydroxy-dec-(4Z)-enoyl-CoA, formula: C31H48N7O18P3S4-, charge: -4
Create a new metabolite for E.R. (3Z)-nonenal, formula: C9H16O, charge: 0
Create a new metabolite for E.R. (3Z)-nonenoate, formula: C9H15O2, charge: -1
Create a new metabolite for cytosolic (3Z)-nonenoate, formula: C9H15O2, charge: -1
Create a new metabolite for mitochondrial (3Z)-nonenoate, formula: C9H15O2, charge: -1
Create a new metabolite for mitochondrial (3Z)-nonenoyl-CoA, formula: C30H46N7O17P3S4-, charge: -4
Edit MAR01227 to be MAM00936m + MAM02630m -> 4(R)-hydroxy-dodec-(2Z,6Z)-dienoyl-CoA + MAM02041m, GPR: ENSG00000115361 or ENSG00000117054 or ENSG00000177646
Edit MAR01185 to be MAM00935m + MAM02630m -> 4(S)-hydroxy-dodec-(2Z,6Z)-dienoyl-CoA + MAM02041m, GPR: ENSG00000115361 or ENSG00000117054 or ENSG00000177646
Create a new reaction 4(R)-hydroxy-dodec-(2Z,6Z)-dienoyl-CoA + MAM02040m -> 3(S),4(R)-dihydroxy-dodec-(6Z)-dienoyl-CoA, GPR: ENSG00000084754
Create a new reaction 4(S)-hydroxy-dodec-(2Z,6Z)-dienoyl-CoA + MAM02040m -> 3(S),4(S)-dihydroxy-dodec-(6Z)-dienoyl-CoA, GPR: ENSG00000084754
Create a new reaction 3(S),4(R)-dihydroxy-dodec-(6Z)-dienoyl-CoA + MAM02552m -> 3-oxo-4(R)-hydroxy-dodec-(6Z)-dienoyl-CoA + MAM02553m + MAM02039m, GPR: ENSG00000084754
Create a new reaction 3(S),4(S)-dihydroxy-dodec-(6Z)-dienoyl-CoA + MAM02552m -> 3-oxo-4(S)-hydroxy-dodec-(6Z)-dienoyl-CoA + MAM02553m + MAM02039m, GPR: ENSG00000084754
Create a new reaction 3-oxo-4(R)-hydroxy-dodec-(6Z)-dienoyl-CoA + MAM01597m -> 2(R)-hydroxy-dec-(4Z)-enoyl-CoA [m] + MAM02041m, GPR: ENSG00000138029
Create a new reaction 3-oxo-4(S)-hydroxy-dodec-(6Z)-dienoyl-CoA + MAM01597m -> 2(S)-hydroxy-dec-(4Z)-enoyl-CoA [m] + MAM02041m, GPR: ENSG00000138029
Create a new reaction 2(R)-hydroxy-dec-(4Z)-enoyl-CoA + MAM02040m -> 2(R)-hydroxy-dec-(4Z)-enoate + MAM01597m + MAM02039m, GPR: ENSG00000119673 or ENSG00000101473 or ENSG00000123130 or ENSG00000162390 or ENSG00000167315, references: PMID:20470824;PMID:22897136;PMID:25478839
Create a new reaction 2(S)-hydroxy-dec-(4Z)-enoyl-CoA + MAM02040m -> 2(S)-hydroxy-dec-(4Z)-enoate + MAM01597m + MAM02039m, GPR: ENSG00000119673 or ENSG00000101473 or ENSG00000123130 or ENSG00000162390 or ENSG00000167315, references: PMID:20470824;PMID:22897136;PMID:25478839
Create a new reaction 2(R)-hydroxy-dec-(4Z)-enoate [m] -> 2(R)-hydroxy-dec-(4Z)-enoate [c]
Create a new reaction 2(S)-hydroxy-dec-(4Z)-enoate [m] -> 2(S)-hydroxy-dec-(4Z)-enoate [c]
Create a new reaction 2(R)-hydroxy-dec-(4Z)-enoate [c] -> 2(R)-hydroxy-dec-(4Z)-enoate [r]
Create a new reaction 2(S)-hydroxy-dec-(4Z)-enoate [c] -> 2(S)-hydroxy-dec-(4Z)-enoate [r]
Create a new reaction 2(R)-hydroxy-dec-(4Z)-enoate [r] + MAM01371r+ MAM01597r -> 2(R)-hydroxy-dec-(4Z)-enoyl-CoA + MAM01334r + MAM02759r, GPR: ENSG00000167114, references: PMID:28289220
Create a new reaction 2(S)-hydroxy-dec-(4Z)-enoate [r] + MAM01371r + MAM01597r -> 2(S)-hydroxy-dec-(4Z)-enoyl-CoA + MAM01334r + MAM02759r, GPR: ENSG00000167114, references: PMID:28289220
Create a new reaction 3-oxo-4(R)-hydroxy-dodec-(6Z)-dienoyl-CoA -> (3Z)-nonenal + MAM01836r, GPR: ENSG00000105135, references: PMID:28289220
Create a new reaction 3-oxo-4(S)-hydroxy-dodec-(6Z)-dienoyl-CoA -> (3Z)-nonenal + MAM01836r, GPR: ENSG00000105135, references: PMID:28289220
While working on #634, I noticed
MAR01227
andMAR01185
: these appear in between a bunch of reactions that clearly represent β-oxidation of fatty acids, but this chemistry does not correspond to any steps or combination of steps of β-oxidation (or α-, or ω-oxidation):MAR01185
: 4(R)-hydroxy-dodec-(6Z)-enoate [m] + CoA [m] ⇒ (2E)-dodecenoyl-CoA [m] + H+ [m] + O2 [m]MAR01227
: 4(S)-hydroxy-dodec-(6Z)-enoate [m] + CoA [m] ⇒ (2E)-dodecenoyl-CoA [m] + H+ [m] + O2 [m]Also those oxygen molecules seem to be coming from the ketone groups on the hydroxydodecenoates, which seems dubiously real. If instead 4(R/S)-hydroxy-docec-(6Z)-enoate went through one round of normal β-oxidation (see these papers), that would look like:
But then there's a problem: 2-hydroxy-acyl-CoAs cannot undergo β-oxidation, so if one is formed as an intermediate during β-oxidation, HACL1 or ILVBL converts the 2-hydroxy-acyl-CoA into an aldehyde with one fewer carbon than the 2-hydroxyacyl-CoA while releasing a formyl-CoA, then ALDH3A2 converts that aldehyde into a carboxylic acid (source), which can then be turned into an acyl-CoA by an acyl-CoA syntheases and resume “normal” β-oxidation. None of these enzymes are localized to mitochondria: HACL1 is in peroxisomes, ILVBL is in the E.R., and ALDH3A2 can be in either peroxisomes or the E.R. I'm proposing a series of reactions that takes the E.R. route and rejoins the ordinary β-oxidation pathway at (2E)-nonenoyl-CoA (
MAM00056m
):Proposed Changes:
ENSG00000105135
)MAR01227
to beMAM00936m + MAM02630m -> 4(R)-hydroxy-dodec-(2Z,6Z)-dienoyl-CoA + MAM02041m
, GPR:ENSG00000115361 or ENSG00000117054 or ENSG00000177646
MAR01185
to beMAM00935m + MAM02630m -> 4(S)-hydroxy-dodec-(2Z,6Z)-dienoyl-CoA + MAM02041m
, GPR:ENSG00000115361 or ENSG00000117054 or ENSG00000177646
4(R)-hydroxy-dodec-(2Z,6Z)-dienoyl-CoA + MAM02040m -> 3(S),4(R)-dihydroxy-dodec-(6Z)-dienoyl-CoA
, GPR:ENSG00000084754
4(S)-hydroxy-dodec-(2Z,6Z)-dienoyl-CoA + MAM02040m -> 3(S),4(S)-dihydroxy-dodec-(6Z)-dienoyl-CoA
, GPR:ENSG00000084754
3(S),4(R)-dihydroxy-dodec-(6Z)-dienoyl-CoA + MAM02552m -> 3-oxo-4(R)-hydroxy-dodec-(6Z)-dienoyl-CoA + MAM02553m + MAM02039m
, GPR:ENSG00000084754
3(S),4(S)-dihydroxy-dodec-(6Z)-dienoyl-CoA + MAM02552m -> 3-oxo-4(S)-hydroxy-dodec-(6Z)-dienoyl-CoA + MAM02553m + MAM02039m
, GPR:ENSG00000084754
3-oxo-4(R)-hydroxy-dodec-(6Z)-dienoyl-CoA + MAM01597m -> 2(R)-hydroxy-dec-(4Z)-enoyl-CoA [m] + MAM02041m
, GPR:ENSG00000138029
3-oxo-4(S)-hydroxy-dodec-(6Z)-dienoyl-CoA + MAM01597m -> 2(S)-hydroxy-dec-(4Z)-enoyl-CoA [m] + MAM02041m
, GPR:ENSG00000138029
2(R)-hydroxy-dec-(4Z)-enoyl-CoA + MAM02040m -> 2(R)-hydroxy-dec-(4Z)-enoate + MAM01597m + MAM02039m
, GPR:ENSG00000119673 or ENSG00000101473 or ENSG00000123130 or ENSG00000162390 or ENSG00000167315
, references:PMID:20470824;PMID:22897136;PMID:25478839
2(S)-hydroxy-dec-(4Z)-enoyl-CoA + MAM02040m -> 2(S)-hydroxy-dec-(4Z)-enoate + MAM01597m + MAM02039m
, GPR:ENSG00000119673 or ENSG00000101473 or ENSG00000123130 or ENSG00000162390 or ENSG00000167315
, references:PMID:20470824;PMID:22897136;PMID:25478839
2(R)-hydroxy-dec-(4Z)-enoate [m] -> 2(R)-hydroxy-dec-(4Z)-enoate [c]
2(S)-hydroxy-dec-(4Z)-enoate [m] -> 2(S)-hydroxy-dec-(4Z)-enoate [c]
2(R)-hydroxy-dec-(4Z)-enoate [c] -> 2(R)-hydroxy-dec-(4Z)-enoate [r]
2(S)-hydroxy-dec-(4Z)-enoate [c] -> 2(S)-hydroxy-dec-(4Z)-enoate [r]
2(R)-hydroxy-dec-(4Z)-enoate [r] + MAM01371r+ MAM01597r -> 2(R)-hydroxy-dec-(4Z)-enoyl-CoA + MAM01334r + MAM02759r
, GPR:ENSG00000167114
, references:PMID:28289220
2(S)-hydroxy-dec-(4Z)-enoate [r] + MAM01371r + MAM01597r -> 2(S)-hydroxy-dec-(4Z)-enoyl-CoA + MAM01334r + MAM02759r
, GPR:ENSG00000167114
, references:PMID:28289220
3-oxo-4(R)-hydroxy-dodec-(6Z)-dienoyl-CoA -> (3Z)-nonenal + MAM01836r
, GPR:ENSG00000105135
, references:PMID:28289220
3-oxo-4(S)-hydroxy-dodec-(6Z)-dienoyl-CoA -> (3Z)-nonenal + MAM01836r
, GPR:ENSG00000105135
, references:PMID:28289220
(3Z)-nonenal + MAM02552r + MAM02040r -> (3Z)-nonenoate [r] + MAM02553r + 2 MAM02039r
, GPR:ENSG00000072210
, references:PMID:28289220
(3Z)-nonenoate [r] -> (3Z)-nonenoate [c]
(3Z)-nonenoate [c] -> (3Z)-nonenoate [m]
(3Z)-nonenoate [m] + MAM01597m + MAM01371m -> (3Z)-nonenoyl-CoA + MAM01334m + MAM02759m
, GPR:ENSG00000166743
, references:PMID:27351777
(3Z)-nonenoyl-CoA -> MAM00056m
, GPR:ENSG00000167969
The text was updated successfully, but these errors were encountered: